Stay updated on Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.

Latest updates to the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdds a recruitment status notice No longer looking for participants and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), clarifying how to interact with the study page. Removes the alternate heading Intervention / Treatment and updates the revision note from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check15 days agoChange DetectedA new revision label v3.5.5 was added and the previous label v3.5.4 was removed. This reflects an update to the page's software revision history rather than changes to study data or functionality.SummaryDifference0.0%

- Check29 days agoChange DetectedA new citation entry is added under Publications for a 2025 Alzheimer’s Dement paper by Devanarayan V, Ye Y, Zhu L, Tian L, Kramer L, Irizarry M, and Dhadda S, describing prognostic covariates in lecanemab trials. This update broadens the study's scholarly context and points readers to recent research related to natural progression in early Alzheimer’s disease.SummaryDifference0.0%

- Check37 days agoChange DetectedA new revision tag (v3.5.4) was added and the previous tag (v3.5.3) removed, indicating an internal update to the page's versioning or template.SummaryDifference0.0%

- Check51 days agoChange DetectedMalmo, Sweden was removed and Malmö, Sweden was added in the Locations list, updating the Sweden entry to the correct local spelling.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page footer’s software/version label was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” indicating a platform release rather than a change to the underlying trial information.SummaryDifference0.0%

Stay in the know with updates to Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lecanemab Safety, Tolerability & Efficacy in Early Alzheimer's Clinical Trial page.